期刊文献+

RP-HPLC法测定富马酸卢帕他定含量及有关物质 被引量:3

RP-HPLC determination of rupatadine fumarate and its related substances
原文传递
导出
摘要 目的:建立富马酸卢帕他定的HPLC含量测定及有关物质检查方法。方法:采用XTerra-C18(250mm×4.6mm,5μm)柱,以醋酸盐缓冲液(pH4.0)-甲醇(25∶75)为流动相,流速1.0mL·min-1,检测波长244nm。并采用LC-MS/MS法鉴定主要有关物质。结果:有关物质与富马酸卢帕他定分离良好,富马酸卢帕他定浓度在0.2~200μg.mL-1范围内线性良好(r=1.000);最低检测限为0.1μg.mL-1;富马酸卢帕他定中的主要有关物质分别为3-二溴甲基-5-甲基吡啶、地氯雷他定、3,5-二(地氯雷他定代)甲基吡啶。结论:本法专属准确,可用于富马酸卢帕他定的含量和有关物质测定。 Objective:To establish an RP -HPLC method for the determination of rupatadine fumarate and its related substances. Method:The separation was performed on a )(Terra- C18 (250 mm×4. 6 mm,5μm) column,the mobile phase was composed of acetate buffer solution(pH 4. 0) -methanol(25: 75) ,and the flow rate was 1.0 mL·min^-1 with UV detection at 244 nm. LC - MS/MS method was employed for the identification of the major related substances. Results:Rupatadine fumarate and its related substances can be completely separated by the method with a good linear range of 0. 2 -200 μg·mL^-1 (r = 1. 000) and the LOD of 0. 1 μg·mL^-1.The related substances were characterized as 3 - dibromomethyl - 5 - methylpyridine ; desloratadine and 3,5 - di ( desloratadinyl ) methylpyridine. Conclusion: This RP - HPLC method is selective,accurate and suitable for the determination of rupatadine fumarate and its related substances.
出处 《药物分析杂志》 CAS CSCD 北大核心 2009年第5期791-794,共4页 Chinese Journal of Pharmaceutical Analysis
关键词 富马酸卢帕他定 含量测定 有关物质 反相高效液相色谱法 rupatadine fumarate determination related substances RP - HPLC
  • 相关文献

参考文献8

二级参考文献24

  • 1王震宇,朱雄,王尔华.卢帕他定中间体5-甲基吡啶-3-羧酸的合成工艺改进[J].药学进展,2005,29(1):31-33. 被引量:3
  • 2张万金,罗艳,张燕梅.卢帕他定的合成[J].中国医药工业杂志,2006,37(7):433-435. 被引量:7
  • 3安登魁.药物分析[M].北京:人民卫生出版社,1995(第三版)..
  • 4包锦芝.新药品种开发手册[M].北京:国家医药管理局医药工业信息中心,1998.530-532.
  • 5孙毓庆.分析化学[M].北京:人民卫生出版社,1995.331-336.
  • 6STUEBNER P,HORAK F,ZIEGLMAYER R,et al. Effects of rupatadine vs placebo on allergen-induced symptoms in patients exposed to aeroallergens in the Vienna Challenge Chamber[ J ]. Ann Allergy Asthma Immunol,2006,96 ( 1 ) : 37-44.
  • 7BARBANOJ M J, GARCIA-GEA C, ANTONIJOAN R, et al. Evaluation of the cognitive, psychomotor and pharmacokinetic profiles of rupatadine, hydroxyzine and cetirizine, in combination with alcohol, in healthy volunteers [ J]. HtLm Psychopharmacol, 2006 ,21 ( 1 ) : 13-26.
  • 8IZQUIERDO I, MERLOS M, GARCIA-RAFANELL J. Rnpatadine: a new selective histamine HI receptor and platelet-activating factor (PAF) antagonist. A review of pharmacological profile and elinical management of allergic rhinltis [ J ]. Drugs Today ( Barc ) ,2003,39 (6) :451-468.
  • 9Inaki L, Manuel M, Julian G, et al. New selective histamine H, receptor and platelet-activating factor (PAF) antagonist[J]. Drugs of Today, 2003, 39(6):451-468.
  • 10Evan P K, Shiuh-Tzung L, Kannappan C, et al. A General Synthesis of Substituted Fluorenones and Azafuwrenones[ J]. J Org Chem, 1988, 53:3513-3521.

共引文献25

同被引文献9

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部